Esther Albarrán-Rodríguez

Dr. Esther Albarrán-Rodríguez

Universidad de Guadalajara, Guadalajara, Jalisco, Mexico
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2022 in Animals
Verified
Journal Article
Open access
PDF file
YMYordan Martínez
Yordan Martínez
MIMaidelys Iser
Maidelys Iser
MVManuel Valdivié
Manuel Valdivié
MRManuel Rosales
Manuel Rosales
Esther Albarrán-RodríguezEsther Albarrán-Rodríguez
Esther Albarrán-Rodríguez
DCDavid Roman Sánchez Chipres
David Roman Sánchez Chipres
This study evaluated the effect of Agave tequilana (Weber var. azul) stem powder on the growth performance and the intestinal integrity in rabbits. A total of 120 male rabbits [New Zealand × California] were weaned for 35 days and randomized into four dietary treatments, 15 replicates per treatment, and two rabbits per replicate. The treatments consisted of a basal diet (T0) and dietary supplementation with 0.5% (T1), 1.0% (T2) and 1.5% (T3) of Agave tequilana stem powder. The T3 treatment improved the body weight and average daily gain (p < 0.05) compared to the other groups, without affecting viability and feed conversion ratio (p > 0.05). Furthermore, the T3 treatment enhanced (p < 0.05) the thickness of the muscular and mucous layers, and the height, thickness, and number of villi in the duodenum (p < 0.05). However, this treatment (T3) significantly decreased (p < 0.05) values for the area and depth of the crypts in the duodenum and the villus/crypt ratio. Likewise, in the cecum, T3 treatment provoked a marked decrease (p < 0.05) in the depth and thickness of the crypts. The results indicate that the dietary use with 1.5% of A. tequilana stem powder had a natural growth-promoting effect and enhanced the histomorphometry of the concentric layers (muscle and mucosa), villi, and crypts as indicators of intestinal health in rabbits.

20 October 2025 in Toxins
Verified
Journal Article
Open access
PDF file
María Carolina De-Luna-LópezMaría Carolina De-Luna-López
María Carolina De-Luna-López
Arturo G. Valdivia-FloresArturo G. Valdivia-Flores
Arturo G. Valdivia-Flores
TTTeodulo Tristan
Teodulo Tristan
RORaul Ortiz-Martinez
Raul Ortiz-Martinez
Erika Janet Rangel-MuñozErika Janet Rangel-Muñoz
Erika Janet Rangel-Muñoz
ESElizabeth de Santiago-Díaz
Elizabeth de Santiago-Díaz
Aflatoxins (AFs) represent a major threat to poultry health and food safety due to their hepatotoxic, immunosuppressive, and carcinogenic effects. This study evaluated the chemoprotective potential of ethoxyquin (EQ) and N-acetylcysteine (NAC) in laying hens (80.8 and 33.3 mg/kg BW/d) exposed to chronic dietary AFs contamination (0.0–1.5 mg/kg). A total of 360 Hy-Line W36 Leghorn hens were monitored over 72 weeks using biochemical and histopathological analyses of liver and kidney tissues. NAC significantly (p < 0.01) increased hepatic and renal levels of reduced glutathione (GSH) and stimulated glutathione S-transferases (GST) and gamma-glutamyl transferase (GGT) activity, enhancing detoxification. Both agents significantly (p < 0.05) reduced plasma ALT and AST levels, preserved total protein concentrations, and attenuated liver and kidney hypertrophy. EQ demonstrated antioxidant effects, stabilizing enzymatic responses and limiting tissue damage. Histopathological analysis revealed fewer structural alterations and cellular degeneration, especially in the NAC-treated group (p < 0.01). These results suggest that NAC and EQ activate endogenous detoxification mechanisms, both enzymatic and non-enzymatic, effectively mitigating chronic aflatoxin toxicity. Their dietary supplementation offers a safe and sustainable chemoprotection strategy to support poultry health and productivity, particularly in regions facing high mycotoxin exposure.

30 August 2024 in E-CUCBA
Verified
Journal Article
Closed access
JZJalisco Universidad de Guadalajara. Centro Universitario Deciencias Biológicas Y Agropecuarias. Departamentode Medicina Veterinaria. Zapopan
Jalisco Universidad de Guadalajara. Centro Universitario Deciencias Biológicas Y Agropecuarias. Departamentode Medicina Veterinaria. Zapopan
PHPedro Hinojosa-Gómez
Pedro Hinojosa-Gómez
DPDulce Anahí Pérez-Arvizo
Dulce Anahí Pérez-Arvizo
NMNancy Janette Márquez-Delgadillo
Nancy Janette Márquez-Delgadillo
JCJosé Ricardo Cuéllar-Pérez
José Ricardo Cuéllar-Pérez
MRManuel Rosales-Cortés
Manuel Rosales-Cortés
Evaluate the hypoglycemic effects of Kombucha and Ganoderma aqueous extractsin a model of diabetes with streptozotocin. Eight-week-ol male wistar ratsweighimg approximately 180 g were randomized into four groups (12 rats eachgroup). Control group (C), streptozotocin (E) without treatment, Kombucha (K)was given Kombucha extract 324 mg/kg orally, and Ganoderma group (G) wasgiven 250 mg/kg orally both for 45 days. Four animals per group were sacrificedat 2-, 15- and 45-days post treatment. Consumption of water and food wereregistered. Blood glucose and insulin levels were measured by spectrophotometryand the islets of Langerhans in the pancreas were quantified by ELISA assay. Datawere analyzed with an ANOVA two-ways and Tukey’s test as post hoc, Sigmastat3.1 Software was used and 0.05% significance was considered. Among the mainresults found, both extracts presented hypoglycemic effects after 15 days oftreatment. An interaction between the number of islets, insulin synthesis, water,and food consumption were also found with the streptozotocin group thatpresented the lowest average number of islets compared to other groups. Bothextracts showed a hypoglycemic, protective and regenerative effect on thepancreas, with differences observed in the physical condition of the animalstreated with Ganoderma, which showed signs of cachexia.